Take Action: Provide a Comments on Medical Care Barriers
The Centers for Medicare & Medicaid Services (CMS) is seeking public comments on how prior authorization policies affect patient access to laboratory testing. This is a critical opportunity to speak out against harmful administrative barriers that delay or deny medically necessary care.
CMS needs to hear directly from patients, caregivers, advocates, and providers about the real-world impacts of these policies, including treatment delays, coverage denials, repeated blood draws, and unnecessary stress. This is especially critical for patients who require biomarker and other advanced laboratory testing, which enables providers to tailor treatments, monitor disease progression, and predict outcomes.
How You Can Take Action
● Deadline: Click here to submit comments to CMS via Documents.gov by June 15.
● Resources to Help: Linked here, are talking points to help guide your submission, along with step-by-step instructions.
Take Action Today
Submitting your comment takes less than 15 minutes, but its impact can last a
lifetime.
● Docket ID: CMS-2026-1255
● Deadline: Monday, June 15, 2026
● How to Submit: Click below to submit your official comment directly to the
federal portal.
Submit Your Comments Now
Together, we can cut the red tape and put patients ahead of paperwork. Make
your voice heard before June 15!
Background & Context
On April 14, CMS released a sweeping proposed rule to modernize prior authorization for medications and medical services across Medicare Advantage, Medicaid, CHIP, and Marketplace plans. The rule proposes major upgrades, including requiring electronic prior authorizations, shortening decision timeframes, and improving transparency around denials. While the broader rule is a great step toward minimizing delays, CMS has issued a specific Request for Information (RFI) on laboratory testing and durable medical equipment. CMS wants to know exactly how current prior authorization requirements create barriers to care or cause administrative delays. For more details, you can read the HHS Fact Sheet on the Proposed Rule.
Together, we can amplify the patient voice and ensure that prior authorization processes for laboratory tests are truly patient-centered. Please let me know once you have submitted your comments, and forward a copy to me if you can.
Thank you for your partnership, continued advocacy, and support.